To improve the quality of healthcare by providing innovative discovery, development and manufacturing solutions to enable superior therapeutic options for patients
To be the preferred provider of specialist services and proprietary technologies to enable the development and commercialisation of better biopharmaceuticals products
To actively engage with innovators to accelerate the development process for innovative and differentiated products
To sustain a strong reputation as an innovator in the field of biopharmaceutical development
Abzena is a revenue generating life sciences group with its headquarters in the UK and two sites in the US. The Group offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals.About Us
Contact Investor Relations
Our Latest News and Events
Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.
Abzena takes on new facilities in Cambridge, UK and San Diego
Envigo 8th Annual Biologics Symposia, USA
Plainsboro, NJ, USA
21 February 2018
Babraham Bioscience Technologies “Technology Development Laboratory” (TDL) moves to Abzena
Antibodies as Drugs: Translating Molecules into Treatments
Whistler, BC, Canada
25 February 2018
Annual Report 2017
“The past 12 months have been a combination of integration and preparing the Group for significant growth. Integration of our US sites into the Abzena group is starting to deliver the expected revenue synergies. The business now has a solid platform from which to expand."
Chief Executive Officer